Thomas Zimmer Selected Research

Thomas Zimmer Research Topics

2	Neoplasms (Cancer) 01/2021 - 07/2018
1	Mental Disorders (Mental Disorder) 10/2022
1	Mania (Manias) 10/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2022
1	Schizophrenia (Dementia Praecox) 10/2022
1	Sudden Death 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Treatment-Resistant Depressive Disorder 01/2017
1	Pathologic Constriction (Stenosis) 09/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2016
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2016
1	Myotonic Dystrophy (Dystrophia Myotonica) 04/2016
1	Sick Sinus Syndrome 05/2010
1	Long QT Syndrome 03/2008
1	Bundle-Branch Block (Fascicular Block) 03/2008
1	Heart Diseases (Heart Disease) 12/2006
1	Ischemia 01/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2004
1	Autoimmune Hepatitis 02/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2002
1	Infections 02/2002
1	Porphyria Cutanea Tarda 02/2002

5	Sodium Channels (Sodium Channel)IBA 01/2021 - 03/2008
2	Voltage-Gated Sodium ChannelsIBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 12/2006
1	Aripiprazole (Abilify)FDA Link 10/2022
1	Antipsychotic Agents (Antipsychotics)IBA 10/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 09/2016
1	CalciumIBA 09/2016
1	Lidocaine (Xylocaine)FDA LinkGeneric 03/2008
1	KATP ChannelsIBA 01/2004
1	AutoantibodiesIBA 02/2002
1	AntibodiesIBA 02/2002

1	Therapeutics 01/2021
1	Segmental Mastectomy (Lumpectomy) 07/2018